Local Delivery of Therapeutic Boron for Bone Healing Enhancement

Description

This presentation by Susan Mengxiao discusses the local delivery of therapeutic boron to enhance bone healing, specifically its role in treating fracture non-union. The speaker outlines the current use of vitamin D and calcium for increasing bone density and introduces boron as a potential alternative, particularly due to its influence on the Wnt beta-catenin signaling pathway, which is vital for bone regeneration.



The study conducted involved bilateral femoral cortical bone defects in 32 mice, with boron salts injected at the defect site for the experimental group, while the control group received saline. Mice were euthanized at three different post-surgical time points to analyze the effects through Micro CT, histological staining, and immunohistochemistry. The findings revealed a significant increase in bone volume and trabecular thickness in the boron-treated group after 21 days. Additionally, alkaline phosphatase levels, indicating osteoblast activity, peaked sooner in the boron group, suggesting accelerated bone healing.



Though osteoclast activity did not differ significantly between groups, angiogenesis, as indicated by CD34 levels, was enhanced in the boron-treated group at day 14. Thus, the research concludes that the local injection of boron increases bone formation by elevating both osteoblast activity and angiogenesis, while proposing further studies to explore its mechanisms and therapeutic potential for those at risk of fracture complications. Susan expresses hope that boron could eventually serve as a valuable therapeutic option for preventing fracture non-union.

Specialties